OBJECTIVES: To perform a molecular and epidemiologic investigation of multidrug-resistant (MDR) Acinetobacter baumannii in an institution were polyclonal outbreaks have been observed and determine whether these polyclonal outbreaks had an endogenous origin or were caused by in-hospital patient-to-patient transmission. DESIGN: Retrospective analysis of prospectively collected data. SETTING: An epidemiologic and genotypic investigation of incident cases of MDR A. baumannii infection in an Israeli university tertiary care center. PATIENTS: Hospitalized patients with MDR A. baumannii isolated from clinical samples during a 13-week period, from April 15, 2003, through July 15, 2003. INTERVENTION: All patients with new MDR A. baumannii infections were recruited, and isolates were typed using pulsed-field gel electrophoresis. Data on in-hospital movements and consultations were extracted from computerized databases. Quantification of transmission opportunities (TOPs), defined as encounters between an established carrier and a future carrier of MDR A. baumannii, and analysis of ward clusters were performed. RESULTS: We studied 96 MDR A. baumannii isolates, which belonged to 18 different pulsed-field gel electrophoresis clones. In 65% of cases, TOPs involving patients with the same clone were demonstrated, which is significantly greater than the number of TOPs involving patients with different clones (P=.01). CONCLUSION: Although outbreaks of MDR A. baumannii infection may be polyclonal, we believe that patient-to-patient transmission explains most cases of transmission. Polyclonal local outbreaks reflect several clonal outbreaks occurring simultaneously. The cause of polyclonal outbreaks of A. baumannii infections clustered by ward and time remains to be explained.
OBJECTIVES: To perform a molecular and epidemiologic investigation of multidrug-resistant (MDR) Acinetobacter baumannii in an institution were polyclonal outbreaks have been observed and determine whether these polyclonal outbreaks had an endogenous origin or were caused by in-hospital patient-to-patient transmission. DESIGN: Retrospective analysis of prospectively collected data. SETTING: An epidemiologic and genotypic investigation of incident cases of MDR A. baumannii infection in an Israeli university tertiary care center. PATIENTS: Hospitalized patients with MDR A. baumannii isolated from clinical samples during a 13-week period, from April 15, 2003, through July 15, 2003. INTERVENTION: All patients with new MDR A. baumannii infections were recruited, and isolates were typed using pulsed-field gel electrophoresis. Data on in-hospital movements and consultations were extracted from computerized databases. Quantification of transmission opportunities (TOPs), defined as encounters between an established carrier and a future carrier of MDR A. baumannii, and analysis of ward clusters were performed. RESULTS: We studied 96 MDR A. baumannii isolates, which belonged to 18 different pulsed-field gel electrophoresis clones. In 65% of cases, TOPs involving patients with the same clone were demonstrated, which is significantly greater than the number of TOPs involving patients with different clones (P=.01). CONCLUSION: Although outbreaks of MDR A. baumannii infection may be polyclonal, we believe that patient-to-patient transmission explains most cases of transmission. Polyclonal local outbreaks reflect several clonal outbreaks occurring simultaneously. The cause of polyclonal outbreaks of A. baumannii infections clustered by ward and time remains to be explained.
Authors: Pilar Villalón; Sylvia Valdezate; Maria J Medina-Pascual; Virginia Rubio; Ana Vindel; Juan A Saez-Nieto Journal: J Clin Microbiol Date: 2010-12-22 Impact factor: 5.948
Authors: Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith S Kaye Journal: Antimicrob Agents Chemother Date: 2010-03-08 Impact factor: 5.191
Authors: Evan S Snitkin; Adrian M Zelazny; Clemente I Montero; Frida Stock; Lilia Mijares; Patrick R Murray; Julie A Segre Journal: Proc Natl Acad Sci U S A Date: 2011-08-08 Impact factor: 11.205
Authors: Dror Marchaim; Teena Chopra; Jason M Pogue; Federico Perez; Andrea M Hujer; Susan Rudin; Andrea Endimiani; Shiri Navon-Venezia; Jatinder Hothi; Jessica Slim; Christopher Blunden; Maryann Shango; Paul R Lephart; Hossein Salimnia; Deborah Reid; Judy Moshos; Wasif Hafeez; Suchitha Bheemreddy; Ting-Yi Chen; Sorabh Dhar; Robert A Bonomo; Keith S Kaye Journal: Antimicrob Agents Chemother Date: 2010-11-29 Impact factor: 5.191
Authors: Anthony D Harris; J Kristie Johnson; Lisa Pineles; Lyndsay M O'Hara; Robert A Bonomo; Kerri A Thom Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191
Authors: Christin N McQueary; Benjamin C Kirkup; Yuanzheng Si; Miriam Barlow; Luis A Actis; David W Craft; Daniel V Zurawski Journal: J Microbiol Date: 2012-06-30 Impact factor: 3.422
Authors: Won Suk Choi; Su Hyun Kim; Eun Gyong Jeon; Myeung Hee Son; Young Kyung Yoon; Jung-Yeon Kim; Mi Jeong Kim; Jang Wook Sohn; Min Ja Kim; Dae Won Park Journal: J Korean Med Sci Date: 2010-06-17 Impact factor: 2.153
Authors: Jon P Furuno; Joan N Hebden; Harold C Standiford; Eli N Perencevich; Ram R Miller; Anita C Moore; Sandra M Strauss; Anthony D Harris Journal: Am J Infect Control Date: 2008-09 Impact factor: 2.918